214 related articles for article (PubMed ID: 38776081)
41. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
Anglemyer A; Horvath HT; Bero L
Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
[TBL] [Abstract][Full Text] [Related]
42. Assessing the Alignment of Large Language Models With Human Values for Mental Health Integration: Cross-Sectional Study Using Schwartz's Theory of Basic Values.
Hadar-Shoval D; Asraf K; Mizrachi Y; Haber Y; Elyoseph Z
JMIR Ment Health; 2024 Apr; 11():e55988. PubMed ID: 38593424
[TBL] [Abstract][Full Text] [Related]
43. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
Bilandzic A; Fitzpatrick T; Rosella L; Henry D
PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
[TBL] [Abstract][Full Text] [Related]
44. Automatic quantitative stroke severity assessment based on Chinese clinical named entity recognition with domain-adaptive pre-trained large language model.
Gu Z; He X; Yu P; Jia W; Yang X; Peng G; Hu P; Chen S; Chen H; Lin Y
Artif Intell Med; 2024 Apr; 150():102822. PubMed ID: 38553162
[TBL] [Abstract][Full Text] [Related]
45. Bias in Hand Surgical Randomized Controlled Trials: Systematic Review and Meta-Epidemiological Study.
Heikkinen J; Jokihaara J; Das De S; Jaatinen K; Buchbinder R; Karjalainen T
J Hand Surg Am; 2022 Jun; 47(6):526-533. PubMed ID: 35341627
[TBL] [Abstract][Full Text] [Related]
46. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.
Tonin FS; Lopes LA; Rotta I; Bonetti AF; Pontarolo R; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2019 Jun; 41(3):785-792. PubMed ID: 30963446
[TBL] [Abstract][Full Text] [Related]
47. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004080. PubMed ID: 31329285
[TBL] [Abstract][Full Text] [Related]
48. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD004080. PubMed ID: 30353940
[TBL] [Abstract][Full Text] [Related]
49. Risk of bias assessment of randomised controlled trials referenced in the 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care: a cross-sectional review.
Cho Y; Kim C; Kang B
BMJ Open; 2019 May; 9(5):e023725. PubMed ID: 31061016
[TBL] [Abstract][Full Text] [Related]
50. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
[TBL] [Abstract][Full Text] [Related]
51. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
[TBL] [Abstract][Full Text] [Related]
52. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
53. Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.
Robertson C; Ramsay C; Gurung T; Mowatt G; Pickard R; Sharma P;
Res Synth Methods; 2014 Sep; 5(3):200-11. PubMed ID: 26052846
[TBL] [Abstract][Full Text] [Related]
54. Bias of AI-generated content: an examination of news produced by large language models.
Fang X; Che S; Mao M; Zhang H; Zhao M; Zhao X
Sci Rep; 2024 Mar; 14(1):5224. PubMed ID: 38433238
[TBL] [Abstract][Full Text] [Related]
55. Integrating large language models in systematic reviews: a framework and case study using ROBINS-I for risk of bias assessment.
Hasan B; Saadi S; Rajjoub NS; Hegazi M; Al-Kordi M; Fleti F; Farah M; Riaz IB; Banerjee I; Wang Z; Murad MH
BMJ Evid Based Med; 2024 Feb; ():. PubMed ID: 38383136
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.
Savović J; Weeks L; Sterne JA; Turner L; Altman DG; Moher D; Higgins JP
Syst Rev; 2014 Apr; 3():37. PubMed ID: 24731537
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
58. Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.
Barcot O; Boric M; Dosenovic S; Puljak L
BMC Med Res Methodol; 2021 Jul; 21(1):149. PubMed ID: 34275437
[TBL] [Abstract][Full Text] [Related]
59. Benchmarking large language models' performances for myopia care: a comparative analysis of ChatGPT-3.5, ChatGPT-4.0, and Google Bard.
Lim ZW; Pushpanathan K; Yew SME; Lai Y; Sun CH; Lam JSH; Chen DZ; Goh JHL; Tan MCJ; Sheng B; Cheng CY; Koh VTC; Tham YC
EBioMedicine; 2023 Sep; 95():104770. PubMed ID: 37625267
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
